Description
65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-03-10+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-03-10 | +$0 | $0 | 65 VII, INVITRO DIAGNOSTICS, REAGENTS, TEST KITS, & TEST SETS, FSS CONTRACT AWARD |
Related awards · 6
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI TJL1DKTX98S5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79718D0523 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2018 |
Other recipients under 6550 from NAC FEDERAL SUPPLY SCHEDULE (36F797) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36F79726D0099 | ROCHE DIABETES CARE INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2026 |
| 36F79725D0206 | SEKISUI DIAGNOSTICS LLC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79725D0119 | MEDMIRA LABORATORIES INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79725D0105 | US LABEL & RIBBON GROUP, INC | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2025 |
| 36F79724D0201 | ABBOTT MOLECULAR INC. | NAC FEDERAL SUPPLY SCHEDULE (36F797) | $0 | FY2024 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_36F79725D0085_3600 · retrieved 2026-09-26.